Rakuoria Pharmaceutical - Rebound, heading towards a capital and business alliance with South Korea's HK inno.N Corporation.

A rebound has been announced regarding the capital and business partnership agreement with South Korea's HK inno.N Corporation. Additionally, a third-party allotment capital increase will be conducted, allotting HK inno.N Corporation as the allottee, with a payment deadline of April 18 and an issue price of 397 yen, comprising 2,592,100 shares of common stock (the voting rights ratio after fundraising is 10.62%). The amount of funds to be procured (estimated net amount) is 1,017 million yen, which will be used for the foundational management of the drug discovery business.

Fisco JapanMar 23 22:12 ET

Foreign Outflow Persists With RM1.25 Billion Leaving The Market

Business TodayMar 23 21:49 ET

MPOC Projects CPO Price To Hover Between RM4400-RM4600 Amid Shifting Demand

Business TodayMar 17 01:40 ET

Palm Oil Edges Higher on Supply Constraints -- Market Talk

WSJMar 16 22:44 ET

Malaysia's Rubber Production Contracts By 20% In January

Business TodayMar 13 06:39 ET

Crude Palm Oil Prices Should Remain Supported by Tight Supply -- Market Talk

WSJMar 12 23:14 ET